yourstate.us
Home / United States / 21 CFR
21 CFR 556.292

§ 556.292 Gamithromycin.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 556.292, § 556.292 Gamithromycin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87773
Permanent ID
ys:prov:87773@1
SHA-256
ada6241b9b38e1ba3a7b44997a2e39b4a8ce0d0d635ca3451deb2b54dc7423c2

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of gamithromycin is 10 µg/kg of body weight per day. (b) Tolerances. The tolerances for gamithromycin (marker residue) are: (1) Cattle. (i) Liver (target tissue): 500 ppb. (ii) Muscle: 150 ppb. (2) [Reserved] (c) Related conditions of use. See § 522.1014 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.